Skip to content

Pimobendan

Drug profile

Also known as: acardi, UD-CG 115 BS, UDCG 115

YEAR INTRODUCED approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Pimobendan is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1994. DrugCentral lists 2 molecular targets, including PDE3B|PDE3A and AGTR1.

  • Molecular targets: PDE3B|PDE3A and AGTR1 (2 listed in DrugCentral).
  • Molecular formula: C19H18N4O2; molecular weight 334.38 g/mol.

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Phosphodiesterase 3PDE3B|PDE3AinhibitorIC50 6.39
Type-1 angiotensin II receptorAGTR1unknownIC50 4.77

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1994-01-01YEAR INTRODUCED——

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Cardiac failure317.4
Cardiac failure chronic132.0
Renal impairment97.1
Low cardiac output syndrome77.9
Blood pressure decreased60.4
Concomitant disease aggravated50.7
Pulmonary congestion48.3

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Pimobendan is on its molecule page.

Molecular formulaC19H18N4O2
Molecular weight334.38 g/mol
CAS number74150-27-9
InChIKeyGLBJJMFZWDBELO-UHFFFAOYSA-N
PubChem CID4823
COC1=CC=C(C=C1)C1=NC2=C(N1)C=CC(=C2)C1=NNC(=O)CC1C

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Pimobendan work?

Its molecular targets in DrugCentral include PDE3B|PDE3A (inhibitor) and AGTR1.

When was Pimobendan first approved?

Pimobendan was first approved by the YEAR INTRODUCED in 1994.

What is the chemical formula of Pimobendan?

Pimobendan has the molecular formula C19H18N4O2 and a molecular weight of 334.38 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1994-01-01
AgencyYEAR INTRODUCED
Targets2
Indications0
FormulaC19H18N4O2
DrugCentral ID2171
Interactive profile